HPIC logo

Hayat Pharmaceutical Industries Co. PLC Stock Price

ASE:HPIC Community·د.أ30.7m Market Cap
  • 0 Narratives written by author
  • 0 Comments on narratives written by author
  • 0 Fair Values set on narratives written by author

HPIC Share Price Performance

د.أ3.23
0.24 (8.03%)
د.أ3.23
0.24 (8.03%)
Price د.أ3.23

HPIC Community Narratives

There are no narratives available yet.

Trending Discussion

Updated Narratives

No recently updated narratives available.

Snowflake Analysis

Excellent balance sheet average dividend payer.

3 Risks
1 Reward

Hayat Pharmaceutical Industries Co. PLC Key Details

د.أ17.1m

Revenue

د.أ7.0m

Cost of Revenue

د.أ10.1m

Gross Profit

د.أ7.7m

Other Expenses

د.أ2.4m

Earnings

Last Reported Earnings
Dec 31, 2025
Next Reporting Earnings
n/a
0.25
58.98%
13.98%
15.0%
View Full Analysis

About HPIC

Founded
1994
Employees
234
CEO
Maher Mohammed Al Kurdi
WebsiteView website
www.hayatpharma.com

Hayat Pharmaceutical Industries Co. PLC engages in the manufacture and marketing of generic pharmaceutical products in Jordan. It offers products in various therapeutic areas, such as allergies; cardiovascular system; dermatology; gastrointestinal system; infectious disease; inner ear and balance; neurology; pain and inflammation; respiratory system; and vitamins and supplements, as well as men’s and women’s health products. The company was founded in 1994 and is based in Amman, Jordan.

Recent HPIC News & Updates

Recent updates

No updates